Technology for common internet user



Monday, September 8, 2008

How malaria parasites attack blood cells

How malaria parasites attack blood cells

MIT zooms in on malaria-infected cells Work could aid in diagnostics, drug testing

The study establishes the first experimental connection between cell membrane vibration and the pathological state of a living cell.

"You can establish a measurement of membrane-fluctuation changes as a function of the gradual progression from a healthy state to a severely pathological state," said Suresh, who has appointments in materials science and engineering, biological engineering, mechanical engineering and the Harvard-MIT Division of Health Sciences and Technology.

It has been known for more than a century that red blood cell membranes continuously undulate. These vibrations are difficult to study because the measurements involved are so tiny (nanometer, or billionth of a meter, scale), and occur in just microseconds.

Suresh and colleagues have previously shown that the cell membranes of red blood cells invaded by the malaria parasite lose their elasticity, as proteins transported from the parasite attach to the membranes and make them significantly stiffer.

In the new paper, the researchers describe using a technique called diffraction phase microscopy to image living cells over the first 48 hours of malaria parasite maturation inside the cell. They showed that infection reduces elasticity and decreases the vibration frequency of the cell membrane.

The team also used a technique called tomographic phase microscopy, which was developed in Feld's laboratory and is based on the same concept as a CT scan: To create a 3D image, the researchers combine about 100 two-dimensional images taken from different angles. Those images are produced with a technique known as interferometry, in which a light wave passing through a cell is compared with a reference wave that doesn't pass through it.

The technique allowed them to study changes in the refractive index of a cell, which is a measure of how much the speed of light is reduced as it passes through the material.

Images generated by tomographic phase microscopy revealed the degradation of hemoglobin as the malaria parasite interacted with the cell.

In the future, the microscopy technology could be used to develop a diagnostic tool that would detect malaria or other human diseases by measuring cell membrane properties. It could also be used to test the efficacy of potential drugs.

The current project got underway about two years ago, after Suresh gave a talk at the Spectroscopy Laboratory on his work studying the mechanical stiffness of malaria-infected red blood cells. Feld and his colleagues were already working on microscopy techniques to visualize red blood cells, so the groups decided to collaborate.



Healthy RBC exhibits a characteristic biconcave shape (left). During the early stage of parasite maturation (center), the parasitophorus vacuole is shown as yellow region. In the late schizont stage, parasitized RBC is subjected to severe morphological changes (right). The blue regions inside the cell indicate parasite-produced hemozoin, a crystallized form of digested hemoglobin.

Source

Labels:

posted by Anand Kumar Reddy at | 0 Comments

Saturday, August 16, 2008

Use of moisturizing Creams can lead to cancer

Use of moisturizing Creams can lead to cancer

Researchers found several creams caused skin cancer in the specially bred mice, which had been pre-treated with ultraviolet radiation.

The cancers are not melanoma, the deadliest kind of skin cancer, they stressed in their report in the Journal of Investigative Dermatology, but another type called squamous cell carcinoma. Such tumors are slow growing, highly treatable and only fatal if patients fail to have them removed.

Read Full article
Journal of Investigative Dermatology (14 Aug 2008)
Doi:10.1038/jid.2008.241

Labels:

posted by Anand Kumar Reddy at | 0 Comments

Tuesday, August 12, 2008

Anti-AIDS vaccine Trial in Indian lab a success

Anti-AIDS vaccine Trial in Indian lab a success

India's HIV vaccine programme got a major boost with scientists of the Tuberculosis Research Centre (TRC) here reporting significant progress in the first phase of clinical trials for a vaccine to prevent AIDS.

Preliminary results of phase one trial have successfully proved the vaccine's safety and its ability to stimulate immune response (that might provide protection against infection), the centre's head told Times of India.

Confirming the development, TRC director V D Ramanathan said: "The trial was to check the vaccine’s safety and also whether it fulfilled the secondary objective of stimulating immune response. We will announce the results to the world soon after we have the complete analysis of the data."

TRC is affiliated to the Indian Council of Medical Research (ICMR), which, along with National AIDS Control Organisation (NACO) and the International AIDS Vaccine Initiative (IAVI), has spearheaded the vaccine trial in India.

"The Phase I trial of an MVA-based AIDS vaccine candidate (TBC - M4) was conducted at the TRC in Chennai. The preliminary results of the trial showed that the vaccine candidate was generally safe and well tolerated and the frequency of immune responses by volunteers after three injections was good. The phase I trial is over and the final data is under analysis," said Dr Sonali Kochar, Medical Director, IAVI India.

Source: Times of India

Labels:

posted by Anand Kumar Reddy at | 0 Comments

 



Privacy Policy